18 completed, 4 terminated, 2 unknown, 1 not yet recruiting. 13 Phase 3, 4 Phase 2, 3 Phase 1, 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 12, Terminated 1 |
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Not applicable | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Bacterial Pneumonia: new trials by email Literature Review of Bacterial Pneumonia trials Research Report on Bacterial Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE - Characterization of the neutrophil granulocyte epigenome, Characterization of the T-cell immune response to to various oxidatively modified mycobacterial antigens - Asthma, COPD | Not yet recruiting | Research Center Borstel | 100 | 2026-02-01 | 2026-02-04 | |
| A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection Bacteremia Caused by Gram-Negative Bacteria, Bacterial Pneumonia | Recruiting | TTY Biopharm | 480 | 2025-11-26 | 2026-03-09 | |
| Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP) Faropenem, Co-amoxiclav, Clarithromycin 500 mg - Pneumonia, Community-Acquired, Bacterial Pneumonia | Phase 4 | Completed | Dr. Md. Alimur Reza | 129 | 2025-02-20 | 2026-08-04 |
| Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Trimodulin, Placebo (human albumin 1%) - Respiratory Infection, Pneumonia | Phase 3 | Terminated | Biotest | 107 | 2022-12-22 | 2025-06-08 |
| A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 CMTX-101, Placebo - Community-acquired Pneumonia, Bacterial Pneumonia | Phase 1 | Terminated | Clarametyx Biosciences, Inc. | 28 | 2022-11-14 | 2024-10-21 |
| Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients Kunamin®, Favipiravir, Enoxaparin - COVID-19 Respiratory Infection, FLU | Phase 3 | Completed | RAAS Nutritionals, LLC | 71 | 2021-05-29 | 2022-06-14 |
| Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia Omadacycline, Moxifloxacin - Community-acquired Pneumonia, Bacterial Pneumonia | Phase 3 | Completed | Paratek Pharmaceuticals Inc | 670 | 2021-02-25 | 2025-04-09 |
| Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) COVID-19, Viral Pneumonia | Unknown | Hannover Medical School | 400 | 2020-10-01 | 2021-07-07 | |
| Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Cefiderocol, Standard of Care Antibiotic - Bacterial Pneumonia | Phase 1 | Terminated | Shionogi | 7 | 2019-02-20 | 2020-11-05 |
| Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic Surgery Pneumonia, Bacterial Pneumonia | Unknown | Assistance Publique - Hôpitaux de Paris | 200 | 2019-02-07 | 2019-07-25 | |
| Cx611-0204 SEPCELL Study Cx611, Placebo - Bacterial Pneumonia | Phase 1 / Phase 2 | Completed | Tigenix S.A.U. | 84 | 2017-01-30 | 2022-04-06 |
| Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Imipenem, Relebactam, Cilastatin - Bacterial Pneumonia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 537 | 2015-11-24 | 2020-04-16 |
| Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) Omadacycline, Moxifloxacin - Bacterial Pneumonia, Community-Acquired Infections | Phase 3 | Completed | Paratek Pharmaceuticals Inc | 774 | 2015-11-01 | 2019-01-16 |
| Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Inhaled corticosteroid, Placebo - Bacterial Pneumonia, Viral Pneumonia | Phase 3 | Completed | Makerere University | 1010 | 2012-12-01 | 2015-10-27 |
| Clinical Trials to Reduce the Risk of Antimicrobial Resistance IV meropenem, I.V. Meropenem, Parenteral aminoglycoside; tobramycin for injection USP OR gentamicin sulfate injection solution concentrate 5mg.kg IV q24h; amikacin sulfate injection USP 20 mg/kg IV q24h - Bacterial Pneumonia | Phase 2 | Terminated | University of Florida | 43 | 2010-09-01 | 2017-09-29 |
| Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter catheter for mini bronchoalveolar lavage - Bacterial Pneumonia | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 36 | 2009-02-01 | 2011-09-23 |
| Vitamin D Supplementation Prevents Elderly Pneumonia Vitamin D3 - Bacterial Pneumonia | Not applicable | Completed | Tohoku University | 100 | 2008-08-01 | 2009-04-08 |
| Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children Viral Pneumonia, Bacterial Pneumonia | Withdrawn | University of Texas Southwestern Medical Center | 2008-03-24 | 2018-12-26 | ||
| Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia Ceftaroline fosamil for Injection, IV Ceftriaxone, Placebo - Bacterial Pneumonia | Phase 3 | Completed | Forest Laboratories | 606 | 2008-01-01 | 2017-03-14 |
| An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia doripenem - Pneumonia, Bacterial Pneumonia | Phase 2 | Completed | PriCara, Unit of Ortho-McNeil, Inc. | 185 | 2007-08-01 | 2013-09-25 |
Showing 20 of 27. Sign in to see all of them.
Pneumonia, Bacterial (27) · Community-Acquired Pneumonia (9) · Pneumonia (5) · Pneumonia, Viral (5) · Cross Infection (3) · COVID-19 (2) · Community-Acquired Infections (2) · Haemophilus Infections (2) · Healthcare-Associated Pneumonia (2) · Asthma (1) · Avitaminosis (1) · Bacterial Infections (1) · Common Cold (1) · Disease (1) · Influenza, Human (1)
Bacterial Infections and Mycoses (27) · Infections (27) · Lung Diseases (27) · Respiratory Tract Diseases (27) · Bacterial Infections (26) · Respiratory Tract Infections (26) · Pneumonia (22) · Community-Acquired Infections (9) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Disease Attributes (6) · Virus Diseases (6) · Iatrogenic Disease (5) · Gram-Negative Bacterial Infections (3) · RNA Virus Infections (3)
Ceftriaxone (3) · Clarithromycin (3) · Tigecycline (3) · Vancomycin (3) · Ceftaroline (2) · Cilastatin (2) · Imipenem (2) · Injections (2) · Linezolid (2) · Moxifloxacin (2) · omadacycline (2) · telavancin (2) · Acetaminophen (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Catheters (1)
Wyeth is now a wholly owned subsidiary of Pfizer (3) · Assistance Publique - Hôpitaux de Paris (2) · Cumberland Pharmaceuticals (2) · Forest Laboratories (2) · Merck Sharp & Dohme LLC (2) · Paratek Pharmaceuticals Inc (2) · Biotest (1) · Clarametyx Biosciences, Inc. (1) · Dr. Md. Alimur Reza (1) · Hannover Medical School (1) · Makerere University (1) · PriCara, Unit of Ortho-McNeil, Inc. (1) · RAAS Nutritionals, LLC (1) · Research Center Borstel (1) · Shionogi (1)
United States (10) · France (7) · Germany (7) · Hungary (5) · Russia (5) · Spain (5) · Ukraine (5) · Argentina (4) · Bulgaria (4) · Poland (4) · Austria (3) · Belgium (3) · Brazil (3) · Croatia (3) · Georgia (3)
G. Ralph Corey, MD (2) · Amy Manley (1) · Antoni Torres, Prof (1) · George L Drusano, MD (1) · Grace Ndeezi, PhD (1) · Grit Barten-Neiner (1) · Hiroyuki Arai, MD (1) · IM Hoepelman, MD (1) · James K Tumwine, PhD (1) · Jan Heyckendorf, Prof. Dr. med. (1) · Kieu Hoang (1)
PMID 18508226, PMID 21482570, PMID 23357290, PMID 24708675, PMID 25487791, PMID 26702925, PMID 27718118, PMID 29454592, PMID 30597021, PMID 34922058, PMID 18436554, PMID 18990531, PMID 19036672, PMID 19740418, PMID 21482566, PMID 21482568, PMID 22812672, PMID 23882105, PMID 29038277, PMID 30726692, PMID 31367741, PMID 32785589, PMID 33238991, PMID 33326848, PMID 34704389, PMID 35776862, PMID 37383243, PMID 37575994, PMID 37918129, PMID 41586496, PMID 42743113
2015 (2)